Holdings
Prosight Management, LP
As of Sep 30, 2026, Prosight Management, LP reported 30 positions worth US$493M. Largest: Lakefront Biotherapeutics, Shattuck Labs, Inc. and Janux Therapeutics, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Lakefront Biotherapeutics | 2M | US$59.3M | −44,944 | Sep 30, 2026 |
| Shattuck Labs, Inc. | 7.65M | US$52.2M | +1.69M | Sep 30, 2026 |
| Janux Therapeutics, Inc. | 2.94M | US$50.9M | −861K | Sep 30, 2026 |
| Nektar Therapeutics | 785K | US$47.5M | −25,000 | Sep 30, 2026 |
| Abivax SA | 377K | US$37.3M | +269K | Sep 30, 2026 |
| Insmed Incorporated | 238K | US$27.2M | −138K | Sep 30, 2026 |
| Boston Scientific Corporation | 550K | US$24M | −720K | Sep 30, 2026 |
| iRhythm Holdings, Inc. | 201K | US$22.8M | +35,480 | Sep 30, 2026 |
| Privia Health Group, Inc. | 1.05M | US$20.7M | new | Sep 30, 2026 |
| Mineralys Therapeutics, Inc. | 800K | US$20.1M | +350K | Sep 30, 2026 |